IP Library Granted Patent US 11,426,105
Granted Patent B2
US 11,426,105 · App. 16/444,960 · Granted Aug 30, 2022

Flowometry in optical coherence tomography for analyte level estimation

Inventors: Samuel Reichgott (Coopersburg, PA); Walter J. Shakespeare (Macungie, PA); George Kechter (Peoria, IL); Phillip William Wallace (Bernardsville, NJ); Matthew J. Schurman (Richboro, PA)
Assignee: Masimo Corporation
A61B5/14551A61B5/0066A61B5/0073A61B5/026A61B5/0261A61B5/1455A61B5/14532A61B5/14546A61B5/4875A61B5/725A61B5/7221A61B5/7278A61B2576/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,426,105
App. No.
16/444,960
Granted
Aug 30, 2022
Kind
B2
Abstract

Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.

Claims (42)

1. A system comprising:

a processor configured to:

receive, from an optical coherence tomography apparatus, an intensity data measurement for a region of tissue;

pass the intensity data measurement through a first frequency band filter having a first bandwidth to produce a first output;

pass the intensity data measurement through a second frequency band filter having a second bandwidth that is wider than the first bandwidth to produce a second output; and

determine an indication of fluid flow in the region of tissue by comparing the first output and the second output.

2. The system of claim 1 , wherein both the first bandwidth and the second bandwidth are centered at a same base frequency.

3. The system of claim 1 , wherein the processor is further configured to:

in response to determining a positive indication of fluid flow in the region of tissue, determine a blood analyte measurement based on at least some of the intensity data measurement.

4. The system of claim 3 , wherein the blood analyte measurement comprises a measurement of at least one of: blood glucose, blood hemoglobin, or blood oxygen.

5. The system of claim 1 , wherein determining the indication of fluid flow in the region of tissue comprises:

analyze fringe frequency data in the first output and the second output.

6. The system of claim 5 , wherein analyzing fringe frequency data comprises:

analyze frequency modulation in the fringe frequency data in the first output and the second output.

7. The system of claim 5 , wherein analyzing fringe frequency data comprises:

analyze amplitude modulation in the fringe frequency data in the first output and the second output.

8. The system of claim 7 , wherein analyzing fringe frequency data further comprises:

compare speckle intensity in the first output and the second output.

9. The system of claim 1 , wherein determining the indication of fluid flow in the region of tissue comprises:

compare speckle intensity in the first output and the second output.

10. The system of claim 1 , wherein the intensity data measurement comprises a backscattered wide band signal.

11. A system comprising:

a processor configured to:

receive, from an optical coherence tomography apparatus, an intensity data measurement for a region of tissue;

pass the intensity data measurement through a first filter to produce a first output;

pass the intensity data measurement through a second filter to produce a second output; and

analyze fringe frequency data of the first output and the second output to determine an indication of fluid flow in the region of tissue.

12. The system of claim 11 , wherein the processor is further configured to:

in response to determining a positive indication of fluid flow in the region of tissue, analyze the intensity data measurement to determine a blood analyte measurement.

13. The system of claim 12 , wherein the processor is further configured to:

analyze a plurality of intensity data measurements for a same region of tissue to determine the blood analyte measurement.

14. The system of claim 13 , wherein the plurality of intensity data measurements are obtained at a plurality of depths in the same region of tissue.

15. The system of claim 13 , wherein the plurality of intensity data measurements are obtained at a plurality of times for the same region of tissue.

16. The system of claim 12 , wherein the blood analyte measurement comprises a measurement of at least one of: blood glucose, blood hemoglobin, or blood oxygen.

17. The system of claim 11 , wherein analyzing fringe frequency data comprises:

analyze frequency modulation in the fringe frequency data in the first output and the second output.

18. The system of claim 11 , wherein analyzing fringe frequency data comprises:

analyze amplitude modulation in the fringe frequency data in the first output and the second output.

19. The system of claim 18 , wherein analyzing fringe frequency data further comprises:

compare speckle intensity in the first output and the second output.

20. The system of claim 19 , wherein determining the indication of fluid flow in the region of tissue comprises:

compare speckle intensity in the first output and the second output.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2021
From: REICHGOTT, SAMUEL; SHAKESPEARE, WALTER J.; KECHTER, GEORGE; WALLACE, PHILLIP WILLIAM; SCHURMAN, MATTHEW J.
To: GLUCOLIGHT CORPORATION
Reel/Frame 054971/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2021
From: GLUCOLIGHT CORPORATION
To: GLT ACQUISITION CORP.
Reel/Frame 054972/0034 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2021
From: GLT ACQUISITION CORPORATION
To: MASIMO CORPORATION
Reel/Frame 054972/0063 →
Continuity (6)
Continuation 14711610 · May 13, 2015
Continuation 14063977 · Oct 25, 2013
Continuation 12397593 · Mar 4, 2009
Provisional Application 61033584 · Mar 4, 2008
Provisional Application 61068058 · Mar 4, 2008
Related Publication 20190357823A1 · Nov 28, 2019
Cited By (1)
US 12,329,548